Pfizer Inc. (PFE)
USD 22.12
(0.96%)
USD 22.12
(0.96%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 137.21 Billion USD | 35.47% |
| 2022 | 101.28 Billion USD | -2.62% |
| 2021 | 104.01 Billion USD | 14.61% |
| 2020 | 90.75 Billion USD | -12.77% |
| 2019 | 104.04 Billion USD | 8.76% |
| 2018 | 95.66 Billion USD | -4.47% |
| 2017 | 100.14 Billion USD | -10.41% |
| 2016 | 111.77 Billion USD | 9.09% |
| 2015 | 102.46 Billion USD | 4.93% |
| 2014 | 97.65 Billion USD | 2.27% |
| 2013 | 95.48 Billion USD | -8.3% |
| 2012 | 104.12 Billion USD | -1.2% |
| 2011 | 105.38 Billion USD | -1.28% |
| 2010 | 106.74 Billion USD | -12.86% |
| 2009 | 122.5 Billion USD | 129.37% |
| 2008 | 53.4 Billion USD | 6.51% |
| 2007 | 50.14 Billion USD | 15.33% |
| 2006 | 43.47 Billion USD | -16.29% |
| 2005 | 51.93 Billion USD | -6.26% |
| 2004 | 55.4 Billion USD | 7.8% |
| 2003 | 51.39 Billion USD | 94.65% |
| 2002 | 26.4 Billion USD | 26.59% |
| 2001 | 20.86 Billion USD | 19.65% |
| 2000 | 17.43 Billion USD | 49.17% |
| 1999 | 11.68 Billion USD | 23.12% |
| 1998 | 9.49 Billion USD | 28.22% |
| 1997 | 7.4 Billion USD | -3.39% |
| 1996 | 7.66 Billion USD | 6.79% |
| 1995 | 7.17 Billion USD | 6.54% |
| 1994 | 6.73 Billion USD | 24.14% |
| 1993 | 5.42 Billion USD | 12.19% |
| 1992 | 4.83 Billion USD | 5.74% |
| 1991 | 4.57 Billion USD | 16.35% |
| 1990 | 3.93 Billion USD | 4.42% |
| 1989 | 3.76 Billion USD | 12.84% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 128.21 Billion USD | -0.25% |
| 2024 Q3 | 126.91 Billion USD | -1.01% |
| 2024 Q1 | 128.53 Billion USD | -6.32% |
| 2023 Q1 | 94.38 Billion USD | -6.82% |
| 2023 Q4 | 137.21 Billion USD | 16.46% |
| 2023 Q3 | 117.81 Billion USD | -2.53% |
| 2023 Q2 | 120.87 Billion USD | 28.07% |
| 2023 FY | 137.21 Billion USD | 35.47% |
| 2022 Q3 | 102.45 Billion USD | -4.97% |
| 2022 Q1 | 101.15 Billion USD | -2.75% |
| 2022 Q2 | 107.82 Billion USD | 6.59% |
| 2022 FY | 101.28 Billion USD | -2.62% |
| 2022 Q4 | 101.28 Billion USD | -1.14% |
| 2021 Q3 | 103.22 Billion USD | 3.63% |
| 2021 Q4 | 104.01 Billion USD | 0.77% |
| 2021 FY | 104.01 Billion USD | 14.61% |
| 2021 Q2 | 99.6 Billion USD | 10.73% |
| 2021 Q1 | 89.95 Billion USD | -0.88% |
| 2020 FY | 90.75 Billion USD | -12.77% |
| 2020 Q1 | 100.99 Billion USD | -2.93% |
| 2020 Q2 | 113.37 Billion USD | 12.25% |
| 2020 Q3 | 113.48 Billion USD | 0.1% |
| 2020 Q4 | 90.75 Billion USD | -20.03% |
| 2019 Q2 | 96.27 Billion USD | 0.01% |
| 2019 Q1 | 96.26 Billion USD | 0.63% |
| 2019 Q3 | 105.05 Billion USD | 9.11% |
| 2019 Q4 | 104.04 Billion USD | -0.96% |
| 2019 FY | 104.04 Billion USD | 8.76% |
| 2018 Q2 | 94.85 Billion USD | 0.83% |
| 2018 Q3 | 96.17 Billion USD | 1.39% |
| 2018 Q4 | 95.66 Billion USD | -0.53% |
| 2018 FY | 95.66 Billion USD | -4.47% |
| 2018 Q1 | 94.07 Billion USD | -6.06% |
| 2017 Q3 | 111.04 Billion USD | 1.07% |
| 2017 Q2 | 109.86 Billion USD | -0.16% |
| 2017 FY | 100.14 Billion USD | -10.41% |
| 2017 Q1 | 110.03 Billion USD | -1.55% |
| 2017 Q4 | 100.14 Billion USD | -9.82% |
| 2016 Q2 | 107.59 Billion USD | 8.04% |
| 2016 FY | 111.77 Billion USD | 9.09% |
| 2016 Q1 | 99.58 Billion USD | -2.81% |
| 2016 Q3 | 114.82 Billion USD | 6.73% |
| 2016 Q4 | 111.77 Billion USD | -2.66% |
| 2015 FY | 102.46 Billion USD | 4.93% |
| 2015 Q1 | 93.05 Billion USD | -4.71% |
| 2015 Q3 | 103.74 Billion USD | 10.72% |
| 2015 Q4 | 102.46 Billion USD | -1.23% |
| 2015 Q2 | 93.69 Billion USD | 0.69% |
| 2014 Q4 | 97.65 Billion USD | 4.94% |
| 2014 Q3 | 93.05 Billion USD | -2.72% |
| 2014 Q2 | 95.65 Billion USD | 2.04% |
| 2014 FY | 97.65 Billion USD | 2.27% |
| 2014 Q1 | 93.74 Billion USD | -1.82% |
| 2013 Q2 | 100.35 Billion USD | -4.03% |
| 2013 FY | 95.48 Billion USD | -8.3% |
| 2013 Q3 | 97.16 Billion USD | -3.18% |
| 2013 Q4 | 95.48 Billion USD | -1.74% |
| 2013 Q1 | 104.57 Billion USD | 0.43% |
| 2012 FY | 104.12 Billion USD | -1.2% |
| 2012 Q4 | 104.12 Billion USD | 3.61% |
| 2012 Q3 | 100.48 Billion USD | -2.33% |
| 2012 Q1 | 102 Billion USD | -3.2% |
| 2012 Q2 | 102.88 Billion USD | 0.86% |
| 2011 FY | 105.38 Billion USD | -1.28% |
| 2011 Q3 | 105.6 Billion USD | -1.25% |
| 2011 Q2 | 106.93 Billion USD | 2.41% |
| 2011 Q1 | 104.42 Billion USD | -2.18% |
| 2011 Q4 | 105.38 Billion USD | -0.21% |
| 2010 Q1 | 105.03 Billion USD | -14.26% |
| 2010 FY | 106.74 Billion USD | -12.86% |
| 2010 Q4 | 106.74 Billion USD | 3.29% |
| 2010 Q3 | 103.34 Billion USD | -0.81% |
| 2010 Q2 | 104.19 Billion USD | -0.8% |
| 2009 Q2 | 76.1 Billion USD | 21.78% |
| 2009 Q1 | 62.49 Billion USD | 17.01% |
| 2009 FY | 122.5 Billion USD | 129.37% |
| 2009 Q3 | 75.04 Billion USD | -1.39% |
| 2009 Q4 | 122.5 Billion USD | 63.24% |
| 2008 Q3 | 47.75 Billion USD | -4.09% |
| 2008 Q1 | 50.99 Billion USD | 1.69% |
| 2008 Q2 | 49.79 Billion USD | -2.34% |
| 2008 FY | 53.4 Billion USD | 6.51% |
| 2008 Q4 | 53.4 Billion USD | 11.83% |
| 2007 Q2 | 42.3 Billion USD | 11.35% |
| 2007 Q4 | 50.14 Billion USD | 18.21% |
| 2007 FY | 50.14 Billion USD | 15.33% |
| 2007 Q1 | 37.99 Billion USD | -12.61% |
| 2007 Q3 | 42.42 Billion USD | 0.26% |
| 2006 Q4 | 43.47 Billion USD | 11.85% |
| 2006 FY | 43.47 Billion USD | -16.29% |
| 2006 Q1 | 43.35 Billion USD | -16.54% |
| 2006 Q2 | 43.06 Billion USD | -0.67% |
| 2006 Q3 | 38.87 Billion USD | -9.73% |
| 2005 Q2 | 46.99 Billion USD | -15.17% |
| 2005 Q1 | 55.4 Billion USD | -0.01% |
| 2005 FY | 51.93 Billion USD | -6.26% |
| 2005 Q4 | 51.93 Billion USD | 19.3% |
| 2005 Q3 | 43.53 Billion USD | -7.37% |
| 2004 Q2 | 53.25 Billion USD | 0.03% |
| 2004 Q4 | 55.4 Billion USD | 2.9% |
| 2004 Q1 | 53.24 Billion USD | 3.59% |
| 2004 FY | 55.4 Billion USD | 7.8% |
| 2004 Q3 | 53.84 Billion USD | 1.11% |
| 2003 Q3 | 51.52 Billion USD | -4.54% |
| 2003 FY | 51.39 Billion USD | 94.65% |
| 2003 Q1 | 28.08 Billion USD | 6.36% |
| 2003 Q2 | 53.97 Billion USD | 92.19% |
| 2003 Q4 | 51.39 Billion USD | -0.25% |
| 2002 Q4 | 26.4 Billion USD | 1.86% |
| 2002 Q3 | 25.92 Billion USD | 9.2% |
| 2002 Q2 | 23.73 Billion USD | 9.68% |
| 2002 Q1 | 21.64 Billion USD | 3.75% |
| 2002 FY | 26.4 Billion USD | 26.59% |
| 2001 Q1 | 17.39 Billion USD | -0.21% |
| 2001 Q2 | 19.12 Billion USD | 9.93% |
| 2001 Q4 | 20.86 Billion USD | 4.77% |
| 2001 Q3 | 19.91 Billion USD | 4.1% |
| 2001 FY | 20.86 Billion USD | 19.65% |
| 2000 Q2 | 17.07 Billion USD | 70.08% |
| 2000 FY | 17.43 Billion USD | 49.17% |
| 2000 Q4 | 17.43 Billion USD | 0.68% |
| 2000 Q3 | 17.31 Billion USD | 1.44% |
| 2000 Q1 | 10.03 Billion USD | -14.12% |
| 1999 Q2 | 10.98 Billion USD | 10.11% |
| 1999 Q4 | 11.68 Billion USD | 2.04% |
| 1999 FY | 11.68 Billion USD | 23.12% |
| 1999 Q1 | 9.98 Billion USD | 5.14% |
| 1999 Q3 | 11.45 Billion USD | 4.22% |
| 1998 Q3 | 9.53 Billion USD | 16.2% |
| 1998 FY | 9.49 Billion USD | 28.22% |
| 1998 Q1 | 7.76 Billion USD | 4.9% |
| 1998 Q2 | 8.2 Billion USD | 5.63% |
| 1998 Q4 | 9.49 Billion USD | -0.42% |
| 1997 Q4 | 7.4 Billion USD | -6.29% |
| 1997 Q1 | 7.86 Billion USD | 2.58% |
| 1997 Q2 | 8.51 Billion USD | 8.36% |
| 1997 Q3 | 7.9 Billion USD | -7.26% |
| 1997 FY | 7.4 Billion USD | -3.39% |
| 1996 Q4 | 7.66 Billion USD | -4.19% |
| 1996 Q3 | 7.99 Billion USD | 5.43% |
| 1996 Q2 | 7.58 Billion USD | 4.81% |
| 1996 FY | 7.66 Billion USD | 6.79% |
| 1996 Q1 | 7.23 Billion USD | 0.86% |
| 1995 Q2 | 8.07 Billion USD | 3.77% |
| 1995 FY | 7.17 Billion USD | 6.54% |
| 1995 Q1 | 7.77 Billion USD | 15.47% |
| 1995 Q3 | 7.49 Billion USD | -7.16% |
| 1995 Q4 | 7.17 Billion USD | -4.24% |
| 1994 Q1 | 5.76 Billion USD | 6.26% |
| 1994 Q2 | 6.31 Billion USD | 9.53% |
| 1994 Q4 | 6.73 Billion USD | 8.47% |
| 1994 FY | 6.73 Billion USD | 24.14% |
| 1994 Q3 | 6.2 Billion USD | -1.67% |
| 1993 Q4 | 5.42 Billion USD | -9.86% |
| 1993 Q2 | 5.77 Billion USD | 10.31% |
| 1993 FY | 5.42 Billion USD | 12.19% |
| 1993 Q1 | 5.23 Billion USD | 8.27% |
| 1993 Q3 | 6.01 Billion USD | 4.21% |
| 1992 Q3 | 4.62 Billion USD | 3.07% |
| 1992 Q1 | 4.37 Billion USD | -4.46% |
| 1992 Q2 | 4.48 Billion USD | 2.71% |
| 1992 Q4 | 4.83 Billion USD | 4.55% |
| 1992 FY | 4.83 Billion USD | 5.74% |
| 1991 Q4 | 4.57 Billion USD | 17.1% |
| 1991 FY | 4.57 Billion USD | 16.35% |
| 1991 Q1 | 3.6 Billion USD | -8.28% |
| 1991 Q2 | 3.96 Billion USD | 9.99% |
| 1991 Q3 | 3.9 Billion USD | -1.51% |
| 1990 Q1 | 3.18 Billion USD | -15.3% |
| 1990 Q4 | 3.93 Billion USD | 12.75% |
| 1990 Q2 | 3.39 Billion USD | 6.44% |
| 1990 FY | 3.93 Billion USD | 4.42% |
| 1990 Q3 | 3.48 Billion USD | 2.73% |
| 1989 FY | 3.76 Billion USD | 12.84% |
| 1989 Q4 | 3.76 Billion USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AbbVie Inc. | 124.31 Billion USD | -10.376% |
| Bristol-Myers Squibb Company | 65.67 Billion USD | -108.93% |
| Bristol-Myers Squibb Company Ce | 65.67 Billion USD | -108.93% |
| Johnson & Johnson | 98.78 Billion USD | -38.902% |
| Eli Lilly and Company | 53.14 Billion USD | -158.198% |
| Merck & Co., Inc. | 69.04 Billion USD | -98.744% |
| Novartis AG | 53.19 Billion USD | -157.943% |
| Organon & Co. | 12.12 Billion USD | -1031.374% |